Harvard Bioscience Inc (HBIO)

2.95
0.05 1.70
NASDAQ : Health Care
Prev Close 3.00
Open 2.95
Day Low/High 2.90 / 3.00
52 Wk Low/High 2.41 / 5.13
Volume 16.22K
Avg Volume 59.50K
Exchange NASDAQ
Shares Outstanding 34.84M
Market Cap 102.76M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Harvard Bioscience an 'Asymmetrical Long Shot'

Harvard Bioscience an 'Asymmetrical Long Shot'

This isn't a classic Tim Melvin value play, but it's appealing and may reward aggressive but patient investors.

Harvard Bioscience Reports Third Quarter 2016 Financial Results

Harvard Bioscience Reports Third Quarter 2016 Financial Results

Announces the Disposition of AHN Biotechnologie GmbH for $1.7 million

Harvard Bioscience Reports Second Quarter 2016 Financial Results

Harvard Bioscience Reports Second Quarter 2016 Financial Results

Conference Call To Be Held at 8:30 AM ET Today

Harvard Bioscience Reports First Quarter 2016 Financial Results

Harvard Bioscience Reports First Quarter 2016 Financial Results

Conference Call To Be Held at 8:30 AM ET Today

Insider Trading Alert - HBIO, OFG And AVGO Traded By Insiders

Insider Trading Alert - HBIO, OFG And AVGO Traded By Insiders

Stocks with insider trader activity include HBIO, OFG and AVGO

Insider Trading Alert - TINY, CALD And HBIO Traded By Insiders

Insider Trading Alert - TINY, CALD And HBIO Traded By Insiders

Stocks with insider trader activity include TINY, CALD and HBIO

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGYS, DHX, IPWR, KELYA, ORA, SGA, TBPH, WB, YOKU Downgrades: ACAS, AXAS, BGFV, CRZO, DENN, GPOR, HBIO, HOLX, IVR, PEIX, PERI, RGLD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Harvard Bioscience Reports Third Quarter 2015 Financial Results And Updates Outlook For Full-Year 2015

Harvard Bioscience Reports Third Quarter 2015 Financial Results And Updates Outlook For Full-Year 2015

Conference Call to be Held at 8:30 AM ET Today

Harvard Bioscience To Showcase Array Of New Products At Society For Neuroscience 2015 Annual Meeting In Chicago On October 18-21

Harvard Bioscience To Showcase Array Of New Products At Society For Neuroscience 2015 Annual Meeting In Chicago On October 18-21

Three Symposium Events Highlight Newest Electrophysiology Research Tools

Insider Trading Alert - HBIO, NSH And BIOA Traded By Insiders

Insider Trading Alert - HBIO, NSH And BIOA Traded By Insiders

Stocks with insider trader activity include HBIO, NSH and BIOA

Short Interest Expands By 170.8% For HBIO

Short Interest Expands By 170.8% For HBIO

The most recent short interest data has been released by the NASDAQ for the 07/15/2015 settlement date, which shows a 852,919 share increase in total short interest for Harvard Bioscience Inc. , to 1,352,364, an increase of 170.77% since 06/30/2015.